Personalized Medicine March 2011
eyeforpharma has recently developed a landmark event to be held in London on 9th/10th March focusing on the increasingly topical Personalized Medicine.
By on Jan 1, 2011
eyeforpharma has recently developed a landmark event to be held in London on 9th/10th March focusing on the increasingly topical Personalized Medicine. To ensure our readers are kept informed about this exciting area https://www.reutersevents.com/pharma/ has developed a series of insightful articles looking at Personalized Medicine and the role that it could play in pharma's future. Read on below for a summary and link to every piece recently published
Personalized Medicine- A kickstart for innovation - Angelo DePalma
Angelo DePalma reports on how personalized medicine may further weaken the blockbuster model of drug development but open up lucrative new niche markets
How to build value through comparative effectiveness research - Angelo Depalma
Angelo DePalma explores how pharma firms can benefit from comparative effectiveness research (CER) regardless of their drug’s marketplace position
PM- The need for collaborative business models- Clare Sansom
Iain Miller, executive director of theranostics at French in vitro diagnostics company bioMérieux, on the importance of partnerships in personalized medicine
PM- The partnership imperative- Clare Sansom
Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical and diagnostics companies are key to the success of personalized medicine
PM- A systems based approach- Greg Maguire
Dr. Greg Maguire, cofounder and CEO of BioRegenerative Sciences, on the coming personalized medicine revolution in healthcare
PM- Regulating companion diagnostics- Clare Sansom
Clare Sansom reports on why this is a key time for regulating diagnostics
PM- Roche success in skin cancer trial- Clare Sansom
Roche’s potential first-in-class drug could be a crucial milestone in personalized medicine